CD4 and systemic lupus erythematosus: The combination of 5 mM metformin and 2-DG treatment more potently suppressed IFN-γ production and cell proliferation in activated primary human CD4+ T cells, suggesting multiple metabolic networks of activated in human T cells may be the target for the treatment of SLE [68].